View Featured Offers >>
85314
β-Amyloid Antibody Sampler Kit
Primary Antibodies
Antibody Sampler Kit

β-Amyloid Antibody Sampler Kit #85314

Citations (0)
Western blot analysis of the indicated amounts of human Aβ-39 peptide using β-Amyloid (1-39) (D5Y9L) Rabbit mAb.
Western blot analysis of the indicated amounts of human Aβ-37 peptide using β-Amyloid (1-37) (D2A6H) Rabbit mAb.
Western blot analysis of human Aβ-37, Aβ-38, Aβ-39, Aβ-40, Aβ-42, and Aβ-43 peptides (2.5 ng) using β-Amyloid (1-42) (D3E10) Rabbit mAb (upper) or β-Amyloid (D54D2) XP® Rabbit mAb #8243 (lower).
Western blot analysis of brain extracts from 13-month old wild-type and TG2576 mice using β-Amyloid (1-40) (D8Q7I) Rabbit mAb (upper) and β-Actin (D6A8) Rabbit mAb #8457 (lower).
β-Amyloid (pE3 Peptide) (D5N5H) Rabbit mAb specificity is demonstrated using peptide dot blot. β-Amyloid (pE3 Peptide) (D5N5H) Rabbit mAb binds to pre-coated β-amyloid (pE3) peptide but not to β-amyloid (E3) peptide or scrambled β-amyloid (pE3) peptide.
Western blot analysis of extracts from HeLa (human), 3T3L1 (mouse) or C6 (rat) cells, untreated or nocodazole-treated (1 µg/ml, 16-18 hours), using APP Antibody.
After the primary antibody is bound to the target protein, a complex with HRP-linked secondary antibody is formed. The LumiGLO® is added and emits light during enzyme catalyzed decomposition.
Western blot analysis of human Aβ-42, Aβ-40, Aβ-39, Aβ-38, and Aβ-37 peptides (5 ng) using β-Amyloid (D54D2) XP® Rabbit mAb.
Western blot analysis of human Aβ-37, Aβ-38, Aβ-39, Aβ-40, Aβ-42, and Aβ-43 peptides (10 ng) using β-Amyloid (1-39) (D5Y9L) Rabbit mAb (upper) or β-Amyloid (D54D2) XP® Rabbit mAb #8243 (lower).
Western blot analysis of brain extracts from 13-month old wild-type and TG2576 mice using β-Amyloid (1-37) (D2A6H) Rabbit mAb (upper) or β-Actin (D6A8) Rabbit mAb #8457 (lower).
Western blot analysis of the indicated amounts of human Aβ-42 peptide using β-Amyloid (1-42) (D3E10) Rabbit mAb.
Western blot analysis of human Aβ-37, Aβ-38, Aβ-39, Aβ-40, Aβ-42 and Aβ-43 peptides (10 ng) using β-Amyloid (1-40) (D8Q7I) Rabbit mAb (upper) and β-Amyloid (D54D2) XP® Rabbit mAb #8243 (lower).
Western blot analysis of the indicated amounts of human Aβ (pE3-42) and Aβ (1-42) peptides using β-Amyloid (pE3 Peptide) (D5N5H) Rabbit mAb (upper) and β-Amyloid (1-42) (D3E10) Rabbit mAb #12843 (lower).
Western blot analysis of the indicated amounts of human Aβ-42 (left) and Aβ-40 (right) peptides using β-Amyloid (D54D2) XP® Rabbit mAb.
Western blot analysis of human Aβ-37, Aβ-38, Aβ-39, Aβ-40, Aβ-42, and Aβ-43 peptides (10 ng) using β-Amyloid (1-37) (D2A6H) Rabbit mAb (upper) or β-Amyloid (D54D2) XP® Rabbit mAb #8243 (lower).
Western blot analysis of brain extracts from 13-month old wild-type and TG2576 mice using β-Amyloid (1-42) (D3E10) Rabbit mAb (upper) or β-Actin (D6A8) Rabbit mAb #8457 (lower).
Confocal immunofluorescent analysis of hippocampus from wild-type (left) and TG2576 (right) mice using β-Amyloid (1-40) (D8Q7I) Rabbit mAb (green) and β3-Tubulin (TU-20) Mouse mAb #4466 (red). Blue pseudocolor = DRAQ5® #4084 (fluorescent DNA dye).
Immunohistochemical analysis of paraffin-embedded human Alzheimer's brain using β-Amyloid (pE3 Peptide) (D5N5H) Rabbit mAb.
Western blot analysis of human Aβ-42 peptide (1 ng) and human cerebrospinal fluid (CSF) of an AD patient using β-Amyloid (D54D2) XP® Rabbit mAb.
Immunohistochemical analysis of paraffin-embedded Tg2576 mouse model of Alzheimer's brain using β-Amyloid (pE3 Peptide) (D5N5H) Rabbit mAb.
Confocal immunofluorescent analysis of wild-type (left) and Tg2576 mouse model of Alzheimer's brain (right) using β-Amyloid (pE3 Peptide) (D5N5H) Rabbit mAb (green) and β3-Tubulin (TU-20) Mouse mAb #4466 (red). Blue pseudocolor = DRAQ5® #4084 (fluorescent DNA dye).
Confocal immunofluorescent analysis of mouse subicular cortex from an amyloid mouse model of Alzheimer's Disease using β-Amyloid (D54D2) XP® Rabbit mAb #8243 (green) and GFAP (GA5) Mouse mAb #3670 (red). Samples were mounted in ProLong® Gold Antifade Reagent with DAPI #8961 (blue).
To Purchase # 85314
Cat. # Size Qty. Price
85314T
1 Kit  (7 x 20 microliters)

Product Includes Quantity Applications Reactivity MW(kDa) Isotype
APP Antibody 2452 20 µl
  • WB
H M R Mk 100 to 140 Rabbit 
β-Amyloid (1-42) (D3E10) Rabbit mAb 12843 20 µl
  • WB
H 4 Rabbit 
β-Amyloid (1-40) (D8Q7I) Rabbit mAb 12990 20 µl
  • WB
  • IF
H 4 Rabbit IgG
β-Amyloid (1-37) (D2A6H) Rabbit mAb 12467 20 µl
  • WB
H 4 Rabbit IgG
β-Amyloid (1-39) (D5Y9L) Rabbit mAb 12077 20 µl
  • WB
H 4 Rabbit IgG
β-Amyloid (D54D2) XP® Rabbit mAb 8243 20 µl
  • WB
  • IP
  • IF
H 5 Rabbit IgG
β-Amyloid (pE3 Peptide) (D5N5H) Rabbit mAb 14975 20 µl
  • WB
  • IHC
  • IF
H 4 Rabbit IgG
Anti-rabbit IgG, HRP-linked Antibody 7074 100 µl
  • WB
Rab Goat 

Product Description

The β-Amyloid Antibody Sampler Kit provides an economical means of detecting APP and APP unmodified/modified fragments using total and fragment-specific antibodies. The kit includes enough antibody to perform two western blot experiments with each primary antibody.

Specificity / Sensitivity

Each antibody in the β-Amyloid Antibody Sampler Kit specifically detects either total APP protein or indicated modified/unmodified APP fragment. APP Antibody detects endogenous levels of several isoforms of both mature and immature amyloid beta (A4) precursor protein (APP), including APP695, APP770, and APP751. β-Amyloid (1-42 Specific) (D3E10), β-Amyloid (1-40 Specific) (D8Q7I), and β-Amyloid (1-37 Specific) (D2A6H) Rabbit mAbs recognize indicated Aβ fragments using human tissue and human APP transgenic mouse model tissue. The recommended usage of β-Amyloid (1-39 Specific) (D5Y9L) Rabbit mAb is limited to specifically detecting recombinant Aβ-39 fragments. β-Amyloid (D54D2) XP® Rabbit mAb recognizes endogenous levels of total human Aβ peptide using human tissue and human APP transgenic mouse model tissue. β-Amyloid (pE3 Peptide) (D5N5H) Rabbit mAb recognizes endogenous levels of pE3 Aβ peptide in human tissue and human APP transgenic mouse models.

Source / Purification

APP Antibody is a polyclonal antibody produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Thr668 of human APP695 protein. Antibodies are purified by protein A and peptide affinity chromatography. β-Amyloid fragment-specific monoclonal antibodies are produced by immunizing rabbits with synthetic peptides corresponding to residues at the carboxy terminus of each indicated human β-Amyloid fragment. β-Amyloid (D54D2) XP® Rabbit mAb is produced by immunizing animals with a synthetic peptide corresponding to residues near the amino terminus of human β-amyloid peptide (Aβ). β-Amyloid (pE3 Peptide) (D5N5H) Rabbit mAb is produced by immunizing animals with a synthetic peptide corresponding to residues near the amino terminus of human β-amyloid (pE3) peptide.

Background

Amyloid β (Aβ) precursor protein (APP) is a 100-140 kDa transmembrane glycoprotein that exists as several isoforms (1). The amino acid sequence of APP contains an amyloid domain, which can be processed and released by two-step proteolytic cleavage (1). The extracellular deposition and accumulation of the released Aβ fragments form the main components of amyloid plaques in Alzheimer's disease (1). Several fragments corresponding to progressive APP processing at alternative cleavage sites have been identified (2). These include Aβ (1-37), Aβ (1-39), Aβ (1-40), and Aβ (1-42) (2). These fragments can also be N-terminally modified to generate pyroglutamate-3 Aβ (pE3-peptide) (3). Fragment-specific and pan-Aβ antibodies are used to detect and examine relative levels of individual Aβ fragments.

Pathways

Explore pathways related to this product.

Limited Uses

Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.

Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.

For Research Use Only. Not for Use in Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
XP is a registered trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit our Trademark Information page.